Bortezomib and atelectasis Patient Reports February 12, 2012

Bortezomib Side Effects Report #5393395-6
Bortezomib side effect was reported by a Health Professional from UNITED STATES on July 17, 2007. Female patient, weighting 182.5 lb, was diagnosed with non-small cell lung cancer and was treated with Bortezomib. After drug was administered, patient experienced the following side effects: atelectasis, pleural effusion. Bortezomib dosage: 0.7 MG/M2 IV DAY 1,4,8,11. During the same period patient was treated with CARBOPLATIN, DOCETAXEL, MOTRIN, DECADRON, VICODIN, KYTRIL, COMPAZINE, ZOFRAN. Patient was hospitalized. Patient recovered.

Bortezomib Side Effects Report #5399138-4
Bortezomib side effect was reported by a Health Professional from UNITED STATES on July 25, 2007. Female patient, weighting 182.5 lb, was diagnosed with non-small cell lung cancer and was treated with Bortezomib. After drug was administered, patient experienced the following side effects: atelectasis, chest discomfort, disease progression, dyspnoea, neoplasm malignant, pleural effusion. Bortezomib dosage: 0.7 MG/M2 IV DAY 1, 4, 8,11. During the same period patient was treated with CARBOPLATIN, DOCETAXEL, MOTRIN, VICODIN, COMPAZINE, DECADRON, KYTRIL, ZOFRAN. Patient was hospitalized. Patient recovered.

Bortezomib Side Effects Report #5940157-4
Bortezomib side effect was reported by a Physician from UNITED STATES on Oct 31, 2008. Female patient, child 8 years of age, weighting 70.77 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Bortezomib. After drug was administered, patient experienced the following side effects: abdominal pain , aeromona infection, atelectasis, blood culture positive, blood pressure decreased, body temperature increased, chest pain , chills, collapse of lung. Bortezomib dosage: 1.3MG/M2/DAY DAYS 1, 4, 8, 11 IV. During the same period patient was treated with DAPSONE, DEXAMETHASONE, DOCUSATE, FLUCONAZOLE, MIRALAX, ONDANSETRON. Patient was hospitalized. Patient recovered.